766 related articles for article (PubMed ID: 15270586)
1. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy.
Welsh JS; Berta C; Borzillary S; Sam C; Shickell D; Nobile L; Greenberg M; Weiss S; Detorie N
Technol Cancer Res Treat; 2004 Aug; 3(4):359-64. PubMed ID: 15270586
[TBL] [Abstract][Full Text] [Related]
2. Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study.
Herrmann MK; Kertesz T; Gsänger T; Bloch E; Pollul G; Bouabdallaoui M; Strauss A; Herrmann M; Christiansen H; Wolff HA; Hess CF; Hille A
Radiat Oncol; 2012 Feb; 7():24. PubMed ID: 22348595
[TBL] [Abstract][Full Text] [Related]
3. Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancer.
Delouya G; Carrier JF; Béliveau-Nadeau D; Donath D; Taussky D
Radiother Oncol; 2010 Jul; 96(1):43-7. PubMed ID: 20378191
[TBL] [Abstract][Full Text] [Related]
4. Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting.
Fuller CD; Thomas CR; Schwartz S; Golden N; Ting J; Wong A; Erdogmus D; Scarbrough TJ
Phys Med Biol; 2006 Oct; 51(19):4981-93. PubMed ID: 16985282
[TBL] [Abstract][Full Text] [Related]
5. A dual modality phantom for cone beam CT and ultrasound image fusion in prostate implant.
Ng A; Beiki-Ardakan A; Tong S; Moseley D; Siewerdsen J; Jaffray D; Yeung IW
Med Phys; 2008 May; 35(5):2062-71. PubMed ID: 18561682
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
7. Experimental measurements and Monte Carlo simulations of dose perturbation around a nonradioactive brachytherapy seed due to 6- and 18-MV photons.
Steinman JP; Bakhtiari M; Malhotra HK
Brachytherapy; 2012; 11(5):413-20. PubMed ID: 21737357
[TBL] [Abstract][Full Text] [Related]
8. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
[TBL] [Abstract][Full Text] [Related]
9. A simple method for dose fusion from multimodality treatment of prostate cancer: brachytherapy to external beam therapy.
Cao M; Ko SC; Slessinger ED; DesRosiers CM; Johnstone PA; Das IJ
Brachytherapy; 2011; 10(3):214-20. PubMed ID: 20843747
[TBL] [Abstract][Full Text] [Related]
10. Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy.
Munoz F; Fiandra C; Franco P; Guarneri A; Ciammella P; De Stefanis P; Rondi N; Moretto F; Badellino S; Iftode C; Ragona R; Ricardi U
Radiol Med; 2012 Sep; 117(6):1057-70. PubMed ID: 22327924
[TBL] [Abstract][Full Text] [Related]
11. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Walbert HL
Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
[TBL] [Abstract][Full Text] [Related]
13. Prostate motion during standard radiotherapy as assessed by fiducial markers.
Crook JM; Raymond Y; Salhani D; Yang H; Esche B
Radiother Oncol; 1995 Oct; 37(1):35-42. PubMed ID: 8539455
[TBL] [Abstract][Full Text] [Related]
14. Practical issues in the implementation of image-guided radiotherapy for the treatment of prostate cancer within a UK department.
Rimmer YL; Burnet NG; Routsis DS; Twyman N; Hoole AC; Treeby J; Welford D; Fairfoul J; 'Aho T; Vowler SL; Benson RJ
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):22-30. PubMed ID: 17981443
[TBL] [Abstract][Full Text] [Related]
15. Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers.
Landry G; Reniers B; Lutgens L; Murrer L; Afsharpour H; de Haas-Kock D; Visser P; van Gils F; Verhaegen F
Med Phys; 2012 Mar; 39(3):1410-7. PubMed ID: 22380373
[TBL] [Abstract][Full Text] [Related]
16. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.
Moseley DJ; White EA; Wiltshire KL; Rosewall T; Sharpe MB; Siewerdsen JH; Bissonnette JP; Gospodarowicz M; Warde P; Catton CN; Jaffray DA
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):942-53. PubMed ID: 17293243
[TBL] [Abstract][Full Text] [Related]
17. Daily online localization using implanted fiducial markers and its impact on planning target volume for carcinoma prostate.
Khosa R; Nangia S; Chufal KS; Ghosh D; Kaul R; Sharma L
J Cancer Res Ther; 2010; 6(2):172-8. PubMed ID: 20622364
[TBL] [Abstract][Full Text] [Related]
18. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
19. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging.
Schallenkamp JM; Herman MG; Kruse JJ; Pisansky TM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):800-11. PubMed ID: 16199313
[TBL] [Abstract][Full Text] [Related]
20. Real-time intraoperative evaluation of implant quality and dose correction during prostate brachytherapy consistently improves target coverage using a novel image fusion and optimization program.
Zelefsky MJ; Cohen GN; Taggar AS; Kollmeier M; McBride S; Mageras G; Zaider M
Pract Radiat Oncol; 2017; 7(5):319-324. PubMed ID: 28377139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
